Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2. 2007

Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA. kamil.paruch@spcorp.com

Properly substituted pyrazolo[1,5-a]pyrimidines are potent and selective CDK2 inhibitors. Compound 15j is orally available and showed efficacy in a mouse A2780 xenograft model.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000882 Haplorhini A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes). Anthropoidea,Monkeys,Anthropoids,Monkey
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051357 Cyclin-Dependent Kinase 2 A key regulator of CELL CYCLE progression. It partners with CYCLIN E to regulate entry into S PHASE and also interacts with CYCLIN A to phosphorylate RETINOBLASTOMA PROTEIN. Its activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P27 and CYCLIN-DEPENDENT KINASE INHIBITOR P21. Cdk2 Protein Kinase,CDK2 Protein,Cdc2-Related Protein Kinase,p33cdk2 Kinase,Cdc2 Related Protein Kinase,Cyclin Dependent Kinase 2

Related Publications

Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
February 2005, Bioorganic & medicinal chemistry letters,
Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
September 2003, Bioorganic & medicinal chemistry letters,
Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
May 2003, European journal of medicinal chemistry,
Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
November 2008, Bioorganic & medicinal chemistry letters,
Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
March 2013, Current computer-aided drug design,
Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
December 2009, Bioorganic & medicinal chemistry letters,
Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
April 2005, Bioorganic & medicinal chemistry letters,
Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
December 2009, Bioorganic & medicinal chemistry letters,
Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
November 2021, ChemMedChem,
Kamil Paruch, and Michael P Dwyer, and Carmen Alvarez, and Courtney Brown, and Tin-Yau Chan, and Ronald J Doll, and Kerry Keertikar, and Chad Knutson, and Brian McKittrick, and Jocelyn Rivera, and Randall Rossman, and Greg Tucker, and Thierry O Fischmann, and Alan Hruza, and Vincent Madison, and Amin A Nomeir, and Yaolin Wang, and Emma Lees, and David Parry, and Nicole Sgambellone, and Wolfgang Seghezzi, and Lesley Schultz, and Fran Shanahan, and Derek Wiswell, and Xiaoying Xu, and Quiao Zhou, and Ray A James, and Vidyadhar M Paradkar, and Haengsoon Park, and Laura R Rokosz, and Tara M Stauffer, and Timothy J Guzi
January 2008, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!